Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
ECTES 2023
Programm
Personen
Suche
EN
Alle Personen
Marta Kokot-Kierepa
Zurich / CH
Takeda Pharmaceuticals International AG
Sortiert nach Typ
Datum
Vortrag
07.05.2023
12:51
–
12:54
3 Min.
0 Min.
Poster
PS6.03
A phase 3 noninferiority trial to evaluate the efficacy and safety of TAK-330 (4-factor prothrombin complex concentrate [4F-PCC]) versus standard-of-care 4F-PCC for the reversal of factor Xa inhibitor-induced anticoagulation before urgent surgery or an invasive procedure
Emergency surgery
08.05.2023
12:50
–
12:55
3 Min.
2 Min.
Quick shot presentation
QSP11.02
Anticoagulation reversal: The current treatment landscape and unmet needs in the USA
Emergency surgery
Weitere Beteiligungen
07.05.2023
12:51
–
12:54
3 Min.
0 Min.
Poster
PS6.03
A phase 3 noninferiority trial to evaluate the efficacy and safety of TAK-330 (4-factor prothrombin complex concentrate [4F-PCC]) versus standard-of-care 4F-PCC for the reversal of factor Xa inhibitor-induced anticoagulation before urgent surgery or an invasive procedure
Emergency surgery
08.05.2023
12:50
–
12:55
3 Min.
2 Min.
Quick shot presentation
QSP11.02
Anticoagulation reversal: The current treatment landscape and unmet needs in the USA
Emergency surgery
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz